Free Trial

Lyell Immunopharma (LYEL) Short Interest Ratio & Short Volume

$2.67
-0.07 (-2.55%)
(As of 05/20/2024 ET)

Lyell Immunopharma Short Interest Data

Current Short Interest
19,970,000 shares
Previous Short Interest
18,230,000 shares
Change Vs. Previous Month
+9.54%
Dollar Volume Sold Short
$43.33 million
Short Interest Ratio
22.3 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
254,940,000 shares
Float Size
118,130,000 shares
Short Percent of Float
16.91%
Today's Trading Volume
889,801 shares
Average Trading Volume
693,603 shares
Today's Volume Vs. Average
128%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Lyell Immunopharma ?

Sign up to receive the latest short interest report for Lyell Immunopharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

LYEL Short Interest Over Time

LYEL Days to Cover Over Time

LYEL Percentage of Float Shorted Over Time

Lyell Immunopharma Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/202419,970,000 shares $43.33 million +9.5%16.9%22.3 $2.17
4/15/202418,230,000 shares $43.75 million +0.7%15.5%19.8 $2.40
3/31/202418,100,000 shares $40.36 million +74.4%15.5%18.8 $2.23
3/15/202410,380,000 shares $22.42 million -5.2%8.9%10.3 $2.16
2/29/202410,950,000 shares $31.97 million -39.6%9.4%8.9 $2.92
2/15/202418,130,000 shares $34.45 million +67.3%15.7%14.5 $1.90
1/31/202410,840,000 shares $19.84 million -30.6%9.4%8.2 $1.83
1/15/202415,620,000 shares $34.68 million +4.4%12.7%11.8 $2.22
12/31/202314,960,000 shares $29.02 million -13.2%12.1%12.2 $1.94
12/15/202317,240,000 shares $33.10 million -0.6%14.0%15.3 $1.92
11/30/202317,340,000 shares $30.00 million -2.3%14.1%18.8 $1.73
11/15/202317,740,000 shares $36.37 million -7.6%14.4%20.3 $2.05
10/31/202319,200,000 shares $31.78 million -7.3%15.8%25.1 $1.66
10/15/202320,720,000 shares $33.98 million -2.3%17.1%29.2 $1.64
9/30/202321,210,000 shares $31.18 million +1.3%17.5%30 $1.47
9/15/202320,930,000 shares $35.37 million -5.2%17.2%28.3 $1.69
8/31/202322,070,000 shares $52.75 million -3.7%18.3%24.3 $2.39
8/15/202322,910,000 shares $52.46 million -2.5%19.0%23 $2.29
7/31/202323,500,000 shares $67.92 million +1.5%19.6%22 $2.89
7/15/202323,160,000 shares $67.86 million -1.2%19.3%20.9 $2.93
6/30/202323,450,000 shares $74.57 million +3.9%19.6%20.8 $3.18
6/15/202322,580,000 shares $87.16 million +4.9%18.9%18.7 $3.86
5/31/202321,530,000 shares $68.68 million +2.8%18.0%20.1 $3.19
5/15/202320,950,000 shares $63.06 million +3.2%17.5%19.8 $3.01
4/30/202320,300,000 shares $41.21 million -0.7%17.0%20.1 $2.03
4/15/202320,450,000 shares $48.26 million -1.8%17.1%20.9 $2.36
3/31/202320,830,000 shares $49.16 million +1.3%17.4%20.2 $2.36
3/15/202320,560,000 shares $45.03 million +14.2%17.2%19.6 $2.19
2/28/202318,010,000 shares $38.72 million +5.4%15.1%16.2 $2.15
2/15/202317,080,000 shares $42.70 million -2.1%14.3%15.7 $2.50
1/31/202317,440,000 shares $57.03 million -2.9%14.6%15.2 $3.27
1/15/202317,960,000 shares $58.01 million -9.4%15.0%15.5 $3.23
12/30/202219,820,000 shares $68.78 million +15.8%20.3%18 $3.47
12/15/202217,110,000 shares $56.12 million -2.0%17.5%16.1 $3.28
11/30/202217,450,000 shares $73.46 million -5.7%22.0%15.3 $4.21
11/15/202218,510,000 shares $85.15 million -2.5%23.4%16.5 $4.60
10/31/202218,990,000 shares $111.66 million -1.1%23.4%18.6 $5.88
10/15/202219,200,000 shares $125.57 million +5.1%23.6%18.6 $6.54
9/30/202218,270,000 shares $133.92 million +19.3%22.5%18.6 $7.33
9/15/202215,320,000 shares $121.95 million +7.0%19.1%14.7 $7.96
Bill Gates is all about this tiny $2 stock (Ad)

What does Bill Gates know about this tiny company that we don’t? From the outside, it looks like a worthless $2 stock…

>>Click here to discover why Bill Gates is all about this tiny $2 stock.
8/31/202214,320,000 shares $95.94 million -7.2%18.1%15.6 $6.70
8/15/202215,430,000 shares $116.03 million -4.6%19.5%17.1 $7.52
7/31/202216,180,000 shares $90.12 million -4.9%25.4%17.1 $5.57
7/15/202217,010,000 shares $100.36 million -2.4%26.7%19.1 $5.90
6/30/202217,430,000 shares $113.64 million +6.9%27.4%19.3 $6.52
6/15/202216,310,000 shares $77.15 million +1.8%25.6%17.9 $4.73
5/31/202216,030,000 shares $66.36 million +5.6%25.4%13 $4.14
5/15/202215,180,000 shares $60.57 million -2.9%24.1%11.9 $3.99
4/30/202215,640,000 shares $80.23 million -6.0%26.4%12.3 $5.13
4/15/202216,630,000 shares $89.64 million +5.3%28.1%13 $5.39
3/31/202215,800,000 shares $79.79 million +29.7%26.7%12.3 $5.05
3/15/202212,180,000 shares $73.20 million +21.7%21.0%9 $6.01
2/28/202210,010,000 shares $72.47 million +6.0%17.3%11.3 $7.24
2/15/20229,440,000 shares $64.38 million +9.6%16.4%12.4 $6.82
1/31/20228,610,000 shares $48.90 million +2.7%14.9%12.9 $5.68
1/15/20228,380,000 shares $50.62 million +10.1%14.5%14.8 $6.04
12/31/20217,610,000 shares $58.90 million +22.4%13.2%15.1 $7.74
12/15/20216,220,000 shares $55.98 million +17.4%10.8%13 $9.00
11/30/20215,300,000 shares $50.62 million +7.1%9.9%12.1 $9.55
11/15/20214,950,000 shares $54.70 million No Change9.3%10.7 $11.05
10/29/20214,950,000 shares $69.00 million +3.8%9.2%11.5 $13.94
10/15/20214,770,000 shares $63.35 million +11.7%8.9%11 $13.28
9/30/20214,270,000 shares $63.20 million +10.3%8.0%9.1 $14.80
9/15/20213,870,000 shares $51.01 million +15.2%5.2%8.2 $13.18
8/31/20213,360,000 shares $53.05 million +10.2%4.4%7.1 $15.79
8/13/20213,050,000 shares $45.17 million No Change4.0%6.7 $14.81

LYEL Short Interest - Frequently Asked Questions

What is Lyell Immunopharma's current short interest?

Short interest is the volume of Lyell Immunopharma shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 19,970,000 shares of LYEL short. 16.91% of Lyell Immunopharma's shares are currently sold short. Learn More on Lyell Immunopharma's current short interest.

What is a good short interest ratio for Lyell Immunopharma?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LYEL shares currently have a short interest ratio of 22.0. Learn More on Lyell Immunopharma's short interest ratio.

What is a good short interest percentage for Lyell Immunopharma?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 16.91% of Lyell Immunopharma's floating shares are currently sold short.

Is Lyell Immunopharma's short interest increasing or decreasing?

Lyell Immunopharma saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 19,970,000 shares, an increase of 9.5% from the previous total of 18,230,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Lyell Immunopharma's float size?

Lyell Immunopharma currently has issued a total of 254,940,000 shares. Some of Lyell Immunopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lyell Immunopharma currently has a public float of 118,130,000 shares.

How does Lyell Immunopharma's short interest compare to its competitors?

16.91% of Lyell Immunopharma's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Lyell Immunopharma: Mineralys Therapeutics, Inc. (4.46%), Pharming Group (0.01%), Savara Inc (6.37%), Silence Therapeutics plc (0.99%), Calliditas Therapeutics AB (publ) (0.03%), GH Research PLC (5.05%), ORIC Pharmaceuticals, Inc. (15.19%), Phathom Pharmaceuticals, Inc. (41.92%), AnaptysBio, Inc. (18.06%), Stoke Therapeutics, Inc. (15.94%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short Lyell Immunopharma stock?

Short selling LYEL is an investing strategy that aims to generate trading profit from Lyell Immunopharma as its price is falling. LYEL shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Lyell Immunopharma?

A short squeeze for Lyell Immunopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LYEL, which in turn drives the price of the stock up even further.

How often is Lyell Immunopharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LYEL, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:LYEL) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners